Viewing Study NCT02276768

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:40 PM
Ignite Modification Date: 2026-01-04 @ 3:43 AM
Study NCT ID: NCT02276768
Status: COMPLETED
Last Update Posted: 2016-08-10
First Post: 2014-10-20
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: Study on Analgesia of GIC-1001 & GIC-1002 on Visceral Pain, Rectal Sensory Threshold Using the Barostat Method
Sponsor: gicare Pharma Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Pain View
None Cancer View
None Colonic Disease View
Keywords:

Keywords

Keyword Brief Keyword Text View
None rectal distension View
None rectal compliance View
None visceral pain View
None pain intensity View
None barostat View
None distender View
None VAS (Visual Analog Scale) View
None rectal sensory threshold View
None analgesia View
None trimebutine View
None pain management View
None peripheral View
None colon cancer View
None H2S (hydrogen sulfide) View